Azhar R Hussain Selected Research

Azhar R Hussain Research Topics

Disease

27	Neoplasms (Cancer) 09/2017 - 10/2005
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2014 - 12/2006
8	Colorectal Neoplasms (Colorectal Cancer) 07/2015 - 05/2008
6	Primary Effusion Lymphoma 01/2012 - 04/2005
4	Lymphoma (Lymphomas) 02/2014 - 10/2008
4	Papillary Thyroid Cancer 03/2012 - 10/2008
3	Carcinogenesis 02/2014 - 05/2010
2	Ovarian Epithelial Carcinoma 05/2015 - 10/2009
2	Obesity 02/2014 - 11/2009
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2013 - 01/2012
2	Thyroid Neoplasms (Thyroid Cancer) 01/2011 - 01/2011
1	Breast Neoplasms (Breast Cancer) 09/2017
1	Necrosis 07/2010
1	Carcinoma (Carcinomatosis) 11/2009
1	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2008
1	Kaposi Sarcoma (Kaposi's Sarcoma) 04/2005

Drug/Important Bio-Agent (IBA)

6	Phosphotransferases (Kinase)IBA 02/2014 - 05/2010
5	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 09/2017 - 01/2011
5	Bortezomib (Velcade)FDA Link 02/2014 - 05/2008
4	Leptin ReceptorsIBA 02/2014 - 11/2009
4	LeptinIBA 02/2014 - 11/2009
3	Proteins (Proteins, Gene)FDA Link 07/2012 - 04/2005
3	LigandsIBA 03/2012 - 07/2010
3	5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA 03/2012 - 01/2011
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 12/2011 - 09/2010
3	Fatty Acid Synthases (Fatty Acid Synthase)IBA 05/2010 - 10/2008
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2009 - 04/2005
3	Protein Kinases (Protein Kinase)IBA 10/2009 - 05/2008
2	embelinIBA 09/2017 - 07/2015
2	Cisplatin (Platino)FDA LinkGeneric 05/2015 - 01/2011
2	Calcibiotic Root Canal SealerIBA 02/2014 - 11/2009
2	thymoquinoneIBA 01/2013 - 04/2011
2	Thiostrepton (Gargon)IBA 07/2012 - 01/2012
2	Proto-Oncogene Proteins c-metIBA 03/2012 - 01/2011
2	X-Linked Inhibitor of Apoptosis ProteinIBA 01/2012 - 10/2010
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2011 - 07/2010
2	EnzymesIBA 05/2010 - 07/2009
2	UbiquitinIBA 10/2009 - 05/2008
2	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2009 - 05/2008
2	CurcuminIBA 10/2008 - 10/2005
2	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2006 - 04/2005
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 09/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2015
1	Mechanistic Target of Rapamycin Complex 2IBA 07/2014
1	Mechanistic Target of Rapamycin Complex 1IBA 07/2014
1	Tumor Biomarkers (Tumor Markers)IBA 07/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2012
1	Transcription Factors (Transcription Factor)IBA 01/2012
1	Matrix Metalloproteinases (MMPs)IBA 01/2012
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 07/2011
1	Biological ProductsIBA 07/2011
1	Ubiquitin-Conjugating EnzymesIBA 05/2011
1	CyclinsIBA 05/2011
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2011
1	ResveratrolIBA 01/2011
1	Decitabine FDA Link 01/2011
1	Inhibitor of Apoptosis ProteinsIBA 10/2010
1	Death Domain ReceptorsIBA 07/2010
1	CytokinesIBA 07/2010
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2010
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2010
1	AdipokinesIBA 11/2009
1	Phospholipids (Phosphatides)FDA LinkGeneric 07/2009
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 07/2009
1	Proteasome InhibitorsIBA 07/2009
1	NF-kappa B (NF-kB)IBA 10/2008
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 10/2008
1	sanguinarineIBA 04/2007

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 02/2014 - 04/2007
2	Therapeutics 07/2015 - 07/2010